Inventaire - your friends and communities are your best library

A model for the stoichiometric regulation of blood coagulation

Published in: Journal of Biological Chemistry

Date of publication: March 13, 2002

Language: English

Bibliographic databases:

Cites articles 33

Date

Title

Authors

October 1, 1979

Phospholipid-binding properties of bovine factor V and factor Va
January 1, 1981

Isolation of functional human coagulation factor V by using a hybridoma antibody
January 1, 1981

Factor V
August 1, 1983

Heterogeneity of human factor V deficiency. Evidence for the existence of antigen-positive variants
December 1, 1988

Antithrombin III deficiency.
October 29, 1991

The coagulation cascade: initiation, maintenance, and regulation
January 1, 1993

Extrinsic pathway proteolytic activity
May 1, 1994

Mutation in blood coagulation factor V associated with resistance to activated protein C.

,
July 1, 1994

Analysis of thrombin generation in plasma
January 1, 1994

Hemophilia A
November 1, 1994

Surface plasmon resonance studies of the interaction between factor VII and tissue factor. Demonstration of defective tissue factor binding in a variant FVII molecule (FVII-R79Q)
March 1, 1994

Cooperative interaction of divalent metal ions, substrate, and tissue factor with factor VIIa
September 1, 1995

Mathematical analysis of activation thresholds in enzyme-catalyzed positive feedbacks: application to the feedbacks of blood coagulation
August 1, 1995

A microscopic model of enzyme kinetics
June 1, 1996

Factor XI deficiency.
February 1, 1996

Kinetics of human factor VII activation
March 1, 1996

Model for the factor VIIIa-dependent decay of the intrinsic factor Xase. Role of subunit dissociation and factor IXa-catalyzed proteolysis
July 1, 1996

Role of the activation peptide domain in human factor X activation by the extrinsic Xase complex
July 1, 1997

Qualitative modeling of normal blood coagulation and its pathological states using stochastic activity networks
August 1, 1997

Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases,Evaluation of the Initiation Phase of Blood Coagulation Using Ultrasensitive Assays for Serine Proteases
March 1, 1997

Inhibitory mechanism of the protein C pathway on tissue factor-induced thrombin generation. Synergistic effect in combination with tissue factor pathway inhibitor
February 1, 1997

Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II
January 1, 1998

Screening test for thrombophilic patients: which tests, for which patient, by whom, when, and why?,Screening Tests for Thrombophilic Patients: Which Tests, for Which Patient, by Whom, When, and Why?
February 1, 1998

Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor,Regulation of Extrinsic Pathway Factor Xa Formation by Tissue Factor Pathway Inhibitor
August 1, 1999

An integrated study of fibrinogen during blood coagulation
August 1, 1999

Macromolecular substrate affinity for the tissue factor-factor VIIa complex is independent of scissile bond docking
May 1, 1999

A model describing the inactivation of factor Va by APC: bond cleavage, fragment dissociation, and product inhibition
March 1, 2000

Regulation of blood coagulation
September 1, 2000

Exosite interactions determine the affinity of factor X for the extrinsic Xase complex
June 1, 2001

The hemophilias--from royal genes to gene therapy
February 7, 2001

Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin
January 3, 2001

Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2.

Article -

Welcome to inventaire

The library of your friends and communities

Learn more